Cardiomyopathy echocardiography or ultrasound: Difference between revisions
No edit summary |
No edit summary |
||
| (8 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cardiomyopathy}} | {{Cardiomyopathy}} | ||
{{CMG}}; {{AE}} [[User:Lina Ya'qoub|Lina Ya'qoub, MD]]; {{EdzelCo}} | |||
==Overview== | ==Overview== | ||
Echocardiography remains the corner stone for establishing the diagnosis of cardiomyopathy, mainly by assessing the systolic and diastolic dysfunction, cardiac chamber diameters and wall thickness as well as valvular diseases. Echocardiography is usually the first diagnostic imaging tool to diagnose cardiomyopathy, although differentiating the cause of the cardiomyopathy based on echocardiography assessment might be difficult in some cases; advanced cardiac imaging, genetic testing and/or biopsy might be needed in some of these cases. | |||
==Cardiomyopathy Echocardiography or Ultrasound== | |||
Echocardiography remains the corner stone for establishing the diagnosis of cardiomyopathy, mainly by assessing the systolic and diastolic dysfunction, cardiac chamber diameters and wall thickness as well as valvular diseases. Echocardiography is usually the first diagnostic imaging tool to diagnose cardiomyopathy, although differentiating the cause of the cardiomyopathy based on echocardiography assessment might be difficult in some cases; advanced cardiac imaging, genetic testing and/or biopsy might be needed in some of these cases.<ref name="pmid15145892">{{cite journal |vauthors=Wood MJ, Picard MH |title=Utility of echocardiography in the evaluation of individuals with cardiomyopathy |journal=Heart |volume=90 |issue=6 |pages=707–12 |date=June 2004 |pmid=15145892 |pmc=1768248 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Cardiology]] | |||
[[Category:Genetic Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date cardiology]] | |||
[[Category:Disease]] | |||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 03:29, 27 October 2023
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy echocardiography or ultrasound |
|
Risk calculators and risk factors for Cardiomyopathy echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Lina Ya'qoub, MD; Edzel Lorraine Co, DMD, MD[2]
Overview
Echocardiography remains the corner stone for establishing the diagnosis of cardiomyopathy, mainly by assessing the systolic and diastolic dysfunction, cardiac chamber diameters and wall thickness as well as valvular diseases. Echocardiography is usually the first diagnostic imaging tool to diagnose cardiomyopathy, although differentiating the cause of the cardiomyopathy based on echocardiography assessment might be difficult in some cases; advanced cardiac imaging, genetic testing and/or biopsy might be needed in some of these cases.
Cardiomyopathy Echocardiography or Ultrasound
Echocardiography remains the corner stone for establishing the diagnosis of cardiomyopathy, mainly by assessing the systolic and diastolic dysfunction, cardiac chamber diameters and wall thickness as well as valvular diseases. Echocardiography is usually the first diagnostic imaging tool to diagnose cardiomyopathy, although differentiating the cause of the cardiomyopathy based on echocardiography assessment might be difficult in some cases; advanced cardiac imaging, genetic testing and/or biopsy might be needed in some of these cases.[1]